QUARTA, ERIDE
 Distribuzione geografica
Continente #
NA - Nord America 1.588
AS - Asia 1.398
EU - Europa 1.311
SA - Sud America 221
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 9
Totale 4.676
Nazione #
US - Stati Uniti d'America 1.528
IT - Italia 518
SG - Singapore 506
CN - Cina 270
VN - Vietnam 254
IE - Irlanda 201
BR - Brasile 166
SE - Svezia 117
HK - Hong Kong 113
DE - Germania 99
NL - Olanda 81
BD - Bangladesh 77
FR - Francia 71
ZA - Sudafrica 47
AT - Austria 40
GB - Regno Unito 36
FI - Finlandia 34
IN - India 33
CA - Canada 32
RU - Federazione Russa 31
TR - Turchia 25
AR - Argentina 22
PL - Polonia 17
TW - Taiwan 17
MX - Messico 16
ID - Indonesia 13
KR - Corea 13
EC - Ecuador 10
ES - Italia 9
IQ - Iraq 8
RS - Serbia 8
MY - Malesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
BE - Belgio 6
CO - Colombia 6
JP - Giappone 6
MA - Marocco 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
IR - Iran 5
JO - Giordania 5
PT - Portogallo 5
UA - Ucraina 5
HR - Croazia 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CL - Cile 3
GA - Gabon 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KY - Cayman, isole 1
LB - Libano 1
MM - Myanmar 1
MR - Mauritania 1
NG - Nigeria 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.604
Città #
Singapore 316
Ashburn 266
San Jose 199
Dublin 197
Parma 136
Dallas 115
Hong Kong 109
Santa Clara 99
Chandler 97
Ho Chi Minh City 74
Council Bluffs 63
Boardman 57
Milan 55
Beijing 54
Hanoi 54
Munich 52
Shanghai 52
Johannesburg 44
New York 40
Ann Arbor 38
Los Angeles 38
Groningen 33
Rome 31
Vienna 30
Bologna 28
Lauterbourg 26
Ferrara 22
Reggio Emilia 22
Turku 22
Hefei 21
Buffalo 19
Brooklyn 18
Da Nang 17
Columbus 15
Haiphong 15
Chicago 13
Hillsboro 13
Seattle 13
Frankfurt am Main 12
Guangzhou 12
Montreal 12
Princeton 12
Amsterdam 11
Helsinki 11
Stockholm 11
Warsaw 11
Atlanta 10
Des Moines 10
Moscow 10
Mumbai 10
Orem 10
Jakarta 9
Marseille 9
Nuremberg 9
Seoul 9
Taipei 9
The Dalles 9
Ardea 8
Mexico City 8
São Paulo 8
Ankara 7
Houston 7
Istanbul 7
Modena 7
Phoenix 7
Tashkent 7
Thái Bình 7
Belgrade 6
Falls Church 6
London 6
Manchester 6
Naples 6
West Jordan 6
Wilmington 6
Abidjan 5
Auckland 5
Bangkok 5
Buenos Aires 5
Denver 5
Figino 5
Fremont 5
Montegaldella 5
Ottawa 5
Padova 5
Puchong Batu Dua Belas 5
San Francisco 5
Segrate 5
Strasbourg 5
Amman 4
Assago 4
Brescia 4
Bắc Ninh 4
Dhaka 4
Genoa 4
Guayaquil 4
Hải Dương 4
Konyaalti 4
Macomer 4
Pune 4
Tokyo 4
Totale 2.942
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 235
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 230
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 209
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 206
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 170
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects 170
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 167
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 159
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 154
Respicell(TM): An innovative dissolution apparatus for inhaled products 154
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 153
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 140
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 140
Nasal delivery as a strategy for the prevention and treatment of COVID-19 136
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 136
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 132
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 130
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 129
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections 127
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 125
LACTOBACILLI INHALATION POWDER FOR THE REDUCTION OF LUNG INFLAMMATION IN non-CF BRONCHIECTASIS DISEASE 116
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 112
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 112
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 108
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation 108
Understanding the importance of capsules in dry powder inhalers 104
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 104
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 103
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms 97
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 80
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 74
Influence of Capsule Size and DPIs Resistance on Inhalable Dry Powder Aerodynamic Performance 37
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases 27
PHARMACOKINETIC PROFILE INVESTIGATION OF PULMONARY SEMAGLUTIDE ENGINEERED POWDER 23
Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus 13
Inhalation drug products of loaded calcium phosphate nanoparticles for heart targeting 9
Totale 4.676
Categoria #
all - tutte 16.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 3 8 5 20 5 12 8 9 1 7 31
2022/2023430 36 49 19 33 27 43 30 35 129 11 9 9
2023/2024438 11 18 8 20 26 59 112 31 24 31 45 53
2024/2025939 28 42 67 101 75 80 79 58 96 72 85 156
2025/20262.391 178 137 313 240 320 142 262 92 327 157 144 79
2026/2027230 119 111 0 0 0 0 0 0 0 0 0 0
Totale 4.676